Safe and Affordable Drugs from Canada Act of 2019
United States116th CongressHR-478House of Representatives
Updated: Jan 25, 2019
Summary
Safe and Affordable Drugs from Canada Act of 2019 This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-61: Safe and Affordable Drugs from Canada Act of 2019Introduced in Senate
Referred to the House Committee on Energy and Commerce.
House of Representatives
Introduced in House
Referred to the Subcommittee on Health.
House of Representatives
All available records shown.